GlaxoSmithKline has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval of an additional indication for Synflorix in the European Union (EU). This ...
Synflorix™ (10-valent pneumococcal conjugate vaccine; GlaxoSmithKline Biologicals, Belgium) has been investigated globally to evaluate immunogenicity, safety and reactogenicity with different ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback